A forgotten drug is giving new hope to kids with a rare disease

A decades-old drug once used to treat sleeping sickness is now showing surprising promise against an ultra-rare and life-threatening genetic disorder called Bachmann-Bupp syndrome (BABS). Early patient treatments suggest the drug, DFMO, may ease severe symptoms by targeting the underlying genetic malfunction. Researchers have already treated a handful of patients with encouraging results, but progress has been slowed by regulatory and logistical hurdles.

Embed Badge

Add this badge to your site to show the AI classification for this content.

MarkdownHtmlImage URL

[![Real Press](https://real.press/api/badge/eea7f30d-6631-4205-84b6-30e4c8ba147f)](https://real.press/content/eea7f30d-6631-4205-84b6-30e4c8ba147f)Copy